{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:41:26Z","timestamp":1779910886582,"version":"3.53.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>In cancer of unknown primary (CUP), positron emission tomography\/computed tomography (PET\/CT) with the glucose analog [<jats:sup>18<\/jats:sup>F]FDG represents the standard imaging approach for localization of the malignant primary. Frequently, however, [<jats:sup>18<\/jats:sup>F]FDG PET\/CT cannot precisely distinguish between small occult tumors and chronic inflammation, especially in Waldeyer\u2019s tonsillar ring. To improve the accuracy for detecting primary tumors in the Waldeyer\u2019s tonsillar ring, the novel PET tracer [<jats:sup>68<\/jats:sup>Ga]Ga-FAPI-4 for specific imaging of fibroblast activation protein (FAP) expression was used as a more specific target for cancer imaging.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Eight patients with suspicion of a malignant tumor in Waldeyer\u2019s tonsillar ring or a CUP syndrome were examined. PET\/CT scans with [<jats:sup>18<\/jats:sup>F]-FDG and [<jats:sup>68<\/jats:sup>Ga]Ga-FAPI-4 were performed for pre-operative tumor localization. After surgical resection, histopathological and immunohistochemical results were compared to PET\/CT findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Histopathology revealed a palatine or lingual tonsil carcinoma in all patients. In case of lymph node metastases smaller than 7 mm in size, the [<jats:sup>18<\/jats:sup>F]FDG PET\/CT detection rate of cervical lymph node metastases was higher than that of [<jats:sup>68<\/jats:sup>Ga]FAPI PET\/CT, while both tracers identified the primary tumors in all eight cases. The size of the primary and the lymph node metastases was directly correlated to the respective FAP expression, as detected by immunohistochemistry. The mean SUV<jats:sub>max<\/jats:sub> for the primary tumors was 21.29 \u00b1 7.97 for <jats:sup>18<\/jats:sup>F-FDG and 16.06 \u00b1 6.29 for <jats:sup>68<\/jats:sup>Ga-FAPI, respectively (<jats:italic>p<\/jats:italic> = 0.2). The mean SUV<jats:sub>max<\/jats:sub> for the healthy contralateral tonsils was 8.38 \u00b1 2.45 for [<jats:sup>18<\/jats:sup>F]FDG and 3.55 \u00b1 0.47 for [<jats:sup>68<\/jats:sup>Ga]FAPI (<jats:italic>p<\/jats:italic> &lt; 0.001). The SUV<jats:sub>max<\/jats:sub> ratio of [<jats:sup>68<\/jats:sup>Ga]FAPI was significantly different from [<jats:sup>18<\/jats:sup>F] FDG (<jats:italic>p<\/jats:italic> = 0.03). Mean TBR<jats:sub>max<\/jats:sub> for the [<jats:sup>68<\/jats:sup>Ga]Ga-FAPI-4 tracer was markedly higher in comparison to [<jats:sup>18<\/jats:sup>F]FDG (10.90 vs. 4.11).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Non-invasive imaging of FAP expression by [<jats:sup>68<\/jats:sup>Ga]FAPI PET\/CT resulted in a better visual detection of the malignant primary in CUP, as compared to [<jats:sup>18<\/jats:sup>F]FDG imaging. However, the detection rate of lymph node metastases was inferior, presumably due to low FAP expression in small metastases. Nevertheless, by offering a detection method for primary tumors with the potential of lower false positive rates and thus avoiding biopsies, patients with CUP syndrome may benefit from [<jats:sup>68<\/jats:sup>Ga]FAPI PET\/CT imaging.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00259-020-05055-8","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:02:34Z","timestamp":1602720154000},"page":"1178-1187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Improved cancer detection in Waldeyer\u2019s tonsillar ring by 68Ga-FAPI PET\/CT imaging"],"prefix":"10.1007","volume":"48","author":[{"given":"S.","family":"Serfling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schirbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gerhard-Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hackenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. K.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Scherzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"issue":"6","key":"5055_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"5055_CR2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0959-8049(02)00023-0","volume":"38","author":"MW van den Brekel","year":"2002","unstructured":"van den Brekel MW, Bindels EM, Balm AJ. Prognostic factors in head and neck cancer. Eur J Cancer. 2002;38(8):1041\u20133.","journal-title":"Eur J Cancer"},{"issue":"3","key":"5055_CR3","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1148\/radiol.14141073","volume":"274","author":"JR Lee","year":"2015","unstructured":"Lee JR, et al. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET\/CT with contrast-enhanced CT or CT\/MR imaging-prospective study. Radiology. 2015;274(3):764\u201371.","journal-title":"Radiology"},{"issue":"3","key":"5055_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1148\/radiology.152.3.6463256","volume":"152","author":"AS Muraki","year":"1984","unstructured":"Muraki AS, Mancuso AA, Harnsberger HR. Metastatic cervical adenopathy from tumors of unknown origin: the role of CT. Radiology. 1984;152(3):749\u201353.","journal-title":"Radiology"},{"issue":"11","key":"5055_CR5","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s002590100626","volume":"28","author":"SN Reske","year":"2001","unstructured":"Reske SN, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, \"Onko-PET III\", 21 July and 19 September 2000. Eur J Nucl Med. 2001;28(11):1707\u201323.","journal-title":"Eur J Nucl Med"},{"issue":"4","key":"5055_CR6","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/hed.20734","volume":"30","author":"J Johansen","year":"2008","unstructured":"Johansen J, et al. Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAHANCA-13 study. Head Neck. 2008;30(4):471\u20138.","journal-title":"Head Neck"},{"issue":"5","key":"5055_CR7","doi-asserted-by":"publisher","first-page":"W519","DOI":"10.2214\/AJR.14.12828","volume":"205","author":"NA Plaxton","year":"2015","unstructured":"Plaxton NA, et al. Characteristics and limitations of FDG PET\/CT for imaging of squamous cell carcinoma of the head and neck: a comprehensive review of anatomy, metastatic pathways, and image findings. AJR Am J Roentgenol. 2015;205(5):W519\u201331.","journal-title":"AJR Am J Roentgenol"},{"issue":"12","key":"5055_CR8","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1002\/lary.20638","volume":"119","author":"M Cianchetti","year":"2009","unstructured":"Cianchetti M, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope. 2009;119(12):2348\u201354.","journal-title":"Laryngoscope"},{"issue":"11","key":"5055_CR9","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/cncr.20687","volume":"101","author":"KE Rusthoven","year":"2004","unstructured":"Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer. 2004;101(11):2641\u20139.","journal-title":"Cancer"},{"issue":"3","key":"5055_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1067\/mhn.2001.114309","volume":"124","author":"WM Koch","year":"2001","unstructured":"Koch WM, et al. Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg. 2001;124(3):331\u20133.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"5055_CR11","doi-asserted-by":"publisher","first-page":"e1155","DOI":"10.1038\/cddis.2014.122","volume":"5","author":"H Wang","year":"2014","unstructured":"Wang H, et al. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN\/PI3K\/AKT and Ras-ERK signaling in oral squamous cell carcinoma. Cell Death Dis. 2014;5:e1155.","journal-title":"Cell Death Dis"},{"issue":"11","key":"5055_CR12","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.neo.2014.09.003","volume":"16","author":"JY Bae","year":"2014","unstructured":"Bae JY, et al. Reciprocal interaction between carcinoma-associated fibroblasts and squamous carcinoma cells through interleukin-1alpha induces cancer progression. Neoplasia. 2014;16(11):928\u201338.","journal-title":"Neoplasia"},{"issue":"9","key":"5055_CR13","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"5055_CR14","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","volume":"87","author":"P Garin-Chesa","year":"1990","unstructured":"Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A. 1990;87(18):7235\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5055_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1158\/1535-7163.MCT-11-0340","volume":"11","author":"WN Brennen","year":"2012","unstructured":"Brennen WN, Isaacs JT, Denmeade SR. Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy. Mol Cancer Ther. 2012;11(2):257\u201366.","journal-title":"Mol Cancer Ther"},{"issue":"32","key":"5055_CR16","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","volume":"37","author":"E Pure","year":"2018","unstructured":"Pure E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018;37(32):4343\u201357.","journal-title":"Oncogene"},{"issue":"2","key":"5055_CR17","first-page":"2793","volume":"61","author":"R Tabola","year":"2017","unstructured":"Tabola R, et al. Fibroblast activating protein-alpha expression in squamous cell carcinoma of the esophagus in primary and irradiated tumors: the use of archival FFPE material for molecular techniques. Eur J Histochem. 2017;61(2):2793.","journal-title":"Eur J Histochem"},{"issue":"9","key":"5055_CR18","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.2967\/jnumed.118.214361","volume":"59","author":"JT Siveke","year":"2018","unstructured":"Siveke JT. Fibroblast-activating protein: targeting the roots of the tumor Microenvironment. J Nucl Med. 2018;59(9):1412\u20134.","journal-title":"J Nucl Med"},{"issue":"3","key":"5055_CR19","doi-asserted-by":"publisher","first-page":"e0116683","DOI":"10.1371\/journal.pone.0116683","volume":"10","author":"F Liu","year":"2015","unstructured":"Liu F, et al. Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis. PLoS One. 2015;10(3):e0116683.","journal-title":"PLoS One"},{"issue":"9","key":"5055_CR20","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, et al. Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein. J Nucl Med. 2018;59(9):1415\u201322.","journal-title":"J Nucl Med"},{"issue":"2","key":"5055_CR21","doi-asserted-by":"publisher","first-page":"165 e17","DOI":"10.1016\/j.crad.2018.10.007","volume":"74","author":"D Pencharz","year":"2019","unstructured":"Pencharz D, et al. Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary. Clin Radiol. 2019;74(2):165 e17\u201323.","journal-title":"Clin Radiol"},{"issue":"24","key":"5055_CR22","doi-asserted-by":"publisher","first-page":"e11040","DOI":"10.1097\/MD.0000000000011040","volume":"97","author":"E Birkin","year":"2018","unstructured":"Birkin E, et al. Determinants of physiological uptake of 18F-fluorodeoxyglucose in palatine tonsils. Medicine (Baltimore). 2018;97(24):e11040.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"5055_CR23","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1158\/1078-0432.CCR-06-1746","volume":"13","author":"LR Henry","year":"2007","unstructured":"Henry LR, et al. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res. 2007;13(6):1736\u201341.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"5055_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4329\/wjr.v6.i5.177","volume":"6","author":"B Tantiwongkosi","year":"2014","unstructured":"Tantiwongkosi B, et al. Role of (18)F-FDG PET\/CT in pre and post treatment evaluation in head and neck carcinoma. World J Radiol. 2014;6(5):177\u201391.","journal-title":"World J Radiol"},{"key":"5055_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.oraloncology.2019.03.014","volume":"92","author":"Y Liu","year":"2019","unstructured":"Liu Y. FDG PET\/CT for metastatic squamous cell carcinoma of unknown primary of the head and neck. Oral Oncol. 2019;92:46\u201351.","journal-title":"Oral Oncol"},{"issue":"8","key":"5055_CR26","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s00259-002-0819-0","volume":"29","author":"G Regelink","year":"2002","unstructured":"Regelink G, et al. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities. Eur J Nucl Med Mol Imaging. 2002;29(8):1024\u201330.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5930","key":"5055_CR27","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029\u201333.","journal-title":"Science"},{"issue":"1","key":"5055_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/snuc.2002.29278","volume":"32","author":"H Zhuang","year":"2002","unstructured":"Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32(1):47\u201359.","journal-title":"Semin Nucl Med"},{"issue":"2","key":"5055_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.emc.2017.12.009","volume":"36","author":"JJ Wall","year":"2018","unstructured":"Wall JJ, Tay KY. Postoperative tonsillectomy hemorrhage. Emerg Med Clin North Am. 2018;36(2):415\u201326.","journal-title":"Emerg Med Clin North Am"},{"issue":"3","key":"5055_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12149-007-0097-9","volume":"22","author":"Y Yamazaki","year":"2008","unstructured":"Yamazaki Y, et al. Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med. 2008;22(3):177\u201384.","journal-title":"Ann Nucl Med"},{"issue":"8","key":"5055_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/v9080219","volume":"9","author":"ME Spurgeon","year":"2017","unstructured":"Spurgeon ME, Lambert PF. Human papillomavirus and the stroma: bidirectional crosstalk during the virus life cycle and carcinogenesis. Viruses. 2017;9(8):219.","journal-title":"Viruses"},{"issue":"1","key":"5055_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13046-018-0802-7","volume":"37","author":"MR Barros Jr","year":"2018","unstructured":"Barros MR Jr, et al. Activities of stromal and immune cells in HPV-related cancers. J Exp Clin Cancer Res. 2018;37(1):137.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-05055-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-020-05055-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-020-05055-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T03:21:37Z","timestamp":1634268097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-020-05055-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["5055"],"URL":"https:\/\/doi.org\/10.1007\/s00259-020-05055-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"1 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Patent application (EP 18155420.5) for quinolone-based FAP targeting agents in nuclear medicine (TL).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approved by the Ethic Committee of the Medical Faculty, University of Wuerzburg (123\/19) for further immunohistopathological examination of FAP from resected tissues.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}